or Try an Advanced Search...

    Technical Analysis for ADXN - Addex Therapeutics Ltd

    Grade Last Price % Change Price Change
    F 8.87 -1.44% -0.13
    ADXN closed down 1.64 percent on Wednesday, May 8, 2024, on 25 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical ADXN trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction -1.44%
    Wide Bands Range Expansion -1.44%
    Oversold Stochastic Weakness -1.44%
    Calm After Storm Range Contraction -3.06%
    Narrow Range Bar Range Contraction -3.06%
    Wide Bands Range Expansion -3.06%
    Oversold Stochastic Weakness -3.06%
    Calm After Storm Range Contraction -3.06%
    Narrow Range Bar Range Contraction -3.06%
    Multiple of Ten Bearish Other -3.06%
    Older End-of-Day Signals for ADXN ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown 28 minutes ago
    Down 1% 28 minutes ago
    Down 3% about 21 hours ago
    Fell Below Previous Day's Low about 21 hours ago
    Down 2 % about 21 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ADXN Chart by TradingView
    Basic chart:

    Profile

    Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Biology Neurological Disorders Urological Disorders Proteins Small Molecule Allosteric Regulation

    Is ADXN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 8 Addex to Present at Bio€quity Europe 2024
    Apr 29 Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Apr 29 Addex stock plunges 50% on failed study for epilepsy drug
    Apr 29 Johnson & Johnson-Partnered Addex Therapeutics' Epilepsy Candidate Fails Mid-Stage Study, Stock Tanks
    Apr 29 Why Philips Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket
    Apr 29 Addex Provides Update on ADX71149 Phase 2 Epilepsy Study
    Apr 19 Addex to Present at the Swiss Biotech Day 2024
    Apr 18 Addex Therapeutics Ltd (ADXN) Q4 2023 Earnings Call Transcript
    Apr 18 Earnings Scheduled For April 18, 2024
    Apr 18 Addex Therapeutics GAAP EPS of -CHF 0.14, revenue of CHF 1.65M
    See more ADXN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 108.0
    52 Week Low 5.04
    Average Volume 24,007
    200-Day Moving Average 24.04
    50-Day Moving Average 14.26
    20-Day Moving Average 15.78
    10-Day Moving Average 9.99
    Average True Range 2.14
    RSI (14) 32.89
    ADX 33.48
    +DI 20.19
    -DI 31.86
    Chandelier Exit (Long, 3 ATRs) 21.49
    Chandelier Exit (Short, 3 ATRs) 13.91
    Upper Bollinger Bands 28.87
    Lower Bollinger Band 2.69
    Percent B (%b) 0.24
    BandWidth 165.93
    MACD Line -2.30
    MACD Signal Line -1.27
    MACD Histogram -1.0338
    Fundamentals Value
    Market Cap 9.54 Million
    Num Shares 1.06 Million
    EPS -20.60
    Price-to-Earnings (P/E) Ratio -0.44
    Price-to-Sales 5.24
    Price-to-Book 2.39
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 10.13
    Resistance 3 (R3) 10.15 9.80 9.94
    Resistance 2 (R2) 9.80 9.51 9.79 9.87
    Resistance 1 (R1) 9.40 9.34 9.23 9.38 9.81
    Pivot Point 9.05 9.05 8.96 9.04 9.05
    Support 1 (S1) 8.65 8.76 8.48 8.63 8.19
    Support 2 (S2) 8.30 8.59 8.29 8.13
    Support 3 (S3) 7.90 8.30 8.06
    Support 4 (S4) 7.88